Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antiviral Peptides: Identification and Validation
Garima Agarwal, Reema Gabrani
International Journal of Peptide Research and Therapeutics (2020) Vol. 27, Iss. 1, pp. 149-168
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

Therapeutic peptides: current applications and future directions
Lei Wang, Nanxi Wang, Wenping Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 1163
A Global Review on Short Peptides: Frontiers and Perspectives
Vasso Apostolopoulos, Joanna Bojarska, Tsun‐Thai Chai, et al.
Molecules (2021) Vol. 26, Iss. 2, pp. 430-430
Open Access | Times Cited: 296
Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds
Mine Erdem Büyükkiraz, Zülal Kesmen
Journal of Applied Microbiology (2021) Vol. 132, Iss. 3, pp. 1573-1596
Closed Access | Times Cited: 289
Immunomodulatory and Allergenic Properties of Antimicrobial Peptides
Svetlana V. Guryanova, Tatiana V. Ovchinnikova
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2499-2499
Open Access | Times Cited: 82
Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update
Uttpal Anand, Shweta Jakhmola, Omkar Indari, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 79
Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study
Shafi Mahmud, Suvro Biswas, Gobindo Kumar Paul, et al.
Arabian Journal of Chemistry (2021) Vol. 14, Iss. 9, pp. 103315-103315
Open Access | Times Cited: 71
ENNAVIA is a novel method which employs neural networks for antiviral and anti-coronavirus activity prediction for therapeutic peptides
Patrick Brendan Timmons, Chandralal M. Hewage
Briefings in Bioinformatics (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 67
Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D
Ming-Yieh Peng, Wen-Chih Liu, Jing-Quan Zheng, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5251-5251
Open Access | Times Cited: 62
Antiviral peptides against Coronaviridae family: A review
Hamid Heydari, Reza Golmohammadi, Reza Mirnejad, et al.
Peptides (2021) Vol. 139, pp. 170526-170526
Open Access | Times Cited: 60
Antimicrobial peptides and their potential application in antiviral coating agents
Emanuelle Dantas de Freitas, Rogério Aparecido Bataglioli, Josephine Oshodi, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 217, pp. 112693-112693
Open Access | Times Cited: 40
Prediction of Antiviral peptides using transform evolutionary & SHAP analysis based descriptors by incorporation with ensemble learning strategy
Shahid Akbar, Farman Ali, Maqsood Hayat, et al.
Chemometrics and Intelligent Laboratory Systems (2022) Vol. 230, pp. 104682-104682
Closed Access | Times Cited: 38
A review of the antiviral activity of cationic antimicrobial peptides
Umme Laila Urmi, Ajay Kumar Vijay, Rajesh Kuppusamy, et al.
Peptides (2023) Vol. 166, pp. 171024-171024
Open Access | Times Cited: 28
DRAVP: A Comprehensive Database of Antiviral Peptides and Proteins
Yanchao Liu, Youzhuo Zhu, Xin Sun, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 820-820
Open Access | Times Cited: 25
Food peptidomic analysis of bovine milk fermented by Lacticaseibacillus casei LBC 237: In silico prediction of bioactive peptides and anticancer potential
Emyr Hiago Bellaver, Eduarda Eliza Redin, Ingrid Militão da Costa, et al.
Food Research International (2024) Vol. 180, pp. 114060-114060
Closed Access | Times Cited: 11
Reimagining Chitosan‐Based Antimicrobial Biomaterials to Mitigate Antibiotic Resistance and Alleviate Antibiotic Overuse: A Review
Khanyisile Sheer Dhlamini, Cyril Tlou Selepe, Bathabile Ramalapa, et al.
Macromolecular Materials and Engineering (2024) Vol. 309, Iss. 9
Open Access | Times Cited: 11
A two-stage computational framework for identifying antiviral peptides and their functional types based on contrastive learning and multi-feature fusion strategy
Jiahui Guan, Lantian Yao, Peilin Xie, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 3
Open Access | Times Cited: 10
Detection strategies of infectious diseases via peptide-based electrochemical biosensors
Simge Balaban Hanoglu, Duygu Harmancı, Serap Evran, et al.
Bioelectrochemistry (2024) Vol. 160, pp. 108784-108784
Closed Access | Times Cited: 8
Perspectives in Peptide-Based Vaccination Strategies for Syndrome Coronavirus 2 Pandemic
Concetta Di Natale, Sara La Manna, Ilaria De Benedictis, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 55
Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives
Karthik Vivekanandhan, Shanmugam Poornima, Hamed Barabadi, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 55
Marine Invertebrate Peptides: Antimicrobial Peptides
Ran Wu, Jiří Patočka, Eugenie Nepovimová, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 53
AI4AVP: an antiviral peptides predictor in deep learning approach with generative adversarial network data augmentation
Tzu-Tang Lin, Yih-Yun Sun, Ching-Tien Wang, et al.
Bioinformatics Advances (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 34
HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: Strategy to combat COVID-19
Liqun Zhang, Santosh K. Ghosh, Shrikanth C. Basavarajappa, et al.
iScience (2022) Vol. 25, Iss. 3, pp. 103856-103856
Open Access | Times Cited: 32
Antiviral Peptides (AVPs) of Marine Origin as Propitious Therapeutic Drug Candidates for the Treatment of Human Viruses
Linda Sukmarini
Molecules (2022) Vol. 27, Iss. 9, pp. 2619-2619
Open Access | Times Cited: 32
Recent Patents and FDA-Approved Drugs Based on Antiviral Peptides and Other Peptide-Related Antivirals
Masoumeh Sadat Mousavi Maleki, Soroush Sardari, Ali Ghandehari Alavijeh, et al.
International Journal of Peptide Research and Therapeutics (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 29
Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infections
Aslaa Ahmed, Gavriella Siman-Tov, Forrest Keck, et al.
Antiviral Research (2019) Vol. 164, pp. 61-69
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top